Advances in clinical laboratory techniques and molecular analysis are reshaping our approach to therapy and diagnosis. Explore emerging diagnostic technology and the latest insights in the microbial community in these webinars.
Ready or not, direct-to-consumer (DTC) genetic testing is here and it is here to stay. As technologies continue to make genetic testing more affordable and accessible to the masses, more indi...
QIAGEN helps your team focus on the opportunities, not the obstacles, with an end-to-end clinical testing solution. During this talk, we will present our clinical decision support solutions,...
Clostridium difficile infection (CDI) has become the leading cause of healthcare associated infections in the United States and currently accounts for 15% to 20% of infectious diarrhea in the...
This presentation illustrates the features of QIAGEN sample to insight approach, and how it combines a powerful chemistry based on unique molecular indexes (UMIs) and a UMI-aware bioinformati...
As reimbursement changes and healthcare moves towards value-based models, the clinical laboratory is faced with the challenge of redefining its value outside the cost per test. This session...
Lab-on-a-chip platforms enable advanced processing, manipulation, and analysis of biological samples in miniaturized fluidic devices. Despite the numerous advantages, such as lower reagent a...
Background and aim: Denmark is a world-wide leading country for the export of swine abroad: Annually 12 mio pigs (nucleus pigs, breeding sows, slaughter pigs and carcasses) are being exporte...
Polypharmacy, the simultaneous use of multiple medications, is growing at an alarming rate with reports documenting a range of 12 to 22 prescriptions being used on average by individuals >...
Up until now, Big Data in healthcare has failed to drive any real progress in curing disease. However, we have just now reached a cost and throughput threshold in sequencing and bioinformati...
On March 16, 2018, the Centers for Medicare and Medicaid Services (CMS) finalized a National Coverage Determination (NCD) for the use of Next Generation Sequencing (NGS) for tumor profiling i...
The availability of CLIA-waived point-of-care tests and the accessibility and training of community pharmacists creates an opportunity for the development of collaborative disease management...
Background and aim: Worldwide malaria cases have declined. However, despite recent advances, resistance to front line drugs and insecticides means the burden remains high (219 million cases...
The World Health Organization (WHO) classified monkeypox as a zoonosis, that is, a disease that is transmitted from animals to humans. Since early May 2022, many instances of monkeypox have...
Drug overdose surpassed motor vehicle accidents as the leading cause of accidental death 2006 and has remained the leading cause of accidental death at the state and national level. Mos...
With the revolution of lateral flow assay use in Point-of-Care and Over-the-Counter testing resulting from Covid-19, saliva has become an attractive sample matrix. To continue to grow latera...
This talk will describe the role of the clinical lab in advancing health equity. It will define the gaps in equitable access to lab testing and how that impacts patient care. We will also co...
Personalized medicine has beomce a paradigm in lung cancer management; ~ 25–30% of advanced lung cancer patients could benefit from a targeted therapy. Several guidelines currently end...
Cancer is a heterogeneous but related group of diseases wherein cells in certain tissues of the body proliferate uncontrollably and eventually invade adjacent and distant tissues. The oldest...
Microorganisms growing in biofilm phenotype are the cause of chronic infections. Several universal properties of biofilm communities are they are overwhelmingly polymicrobial, difficult...
Proteomics offers a deeper understanding of the protein events influencing cellular and biological function. However, identifying key regulated proteins and their implicated signaling pathway...
To prevent and treat SARS-CoV-2 infections, a comprehensive understanding of both the humoral and cellular immune responses is essential. One critical component to understanding the fundamen...
Next-generation DNA sequencing began to enter the clinic a decade ago, a half decade after the draft human reference sequence was published. The discovery of new genes, new variants of...
Each year, more monoclonal antibodies (mAbs) are approved by regulatory agencies to treat a wide range of diseases with an expected market value of over $200 billion by 2026. The advantage o...
In this session, researchers, clinicians, and program implementers from four countries will address the disruption in continuity of care for PLHIV amid the COVID-19 pandemic and the conseque...
...
